The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria in Chronic Non-diabetic Kidney Disease: a Double-blind Cross-over Randomised Controlled Study
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Aliskiren (Primary) ; Eplerenone (Primary) ; Telmisartan (Primary)
- Indications Kidney disorders
- Focus Pharmacodynamics
- 09 Mar 2012 New trial record